- cafead Aug 24, 2023 at 11:52: AM
via As the Federal Trade Commission tries to block Amgen’s $28 billion acquisition of Horizon Therapeutics with an injunction, Amgen has a lot to say in court filings.
The FTC’s case is “far too removed from reality and unmoored from decades of legal precedent,” Amgen’s lawyers wrote in a response to FTC’s request for a preliminary injunction. The company filed the note to a federal court in Illinois on Tuesday.
article source
The FTC’s case is “far too removed from reality and unmoored from decades of legal precedent,” Amgen’s lawyers wrote in a response to FTC’s request for a preliminary injunction. The company filed the note to a federal court in Illinois on Tuesday.
article source